We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Alnylam Presents New Pre-clinical Data on ALN-AT3

News   Dec 10, 2013

 
Alnylam Presents New Pre-clinical Data on ALN-AT3
 
 
 

RELATED ARTICLES

Drug Reduces Menstrual Bleeding for Women with Gynecologic Tumors

News

A new oral drug significantly reduced menstrual bleeding for women with the most common gynecologic tumors in the United States - benign tumors that disproportionately affect African-Americans, an international clinical trial found.

READ MORE


Gold Nanoparticles Act as Tumor-seeking Missiles

News

A small clinical trial using gold nanoparticles that act as tumor-seeking missiles on a mission to remove prostate cancer has begun at The University of Texas Health Science Center at Houston (UTHealth).

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE